1-9 of 9
Els Lierman, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

MPL p.S204P Is a Recurrent Mutation in Essential Thrombocythemia

Carla AL Assaf, Petros Papadopoulos, PhD, Laura Guttierez, PhD, Sanne Smits, Carlos Graux, MDPhD, Jan Emmerechts, MDPhD, Els Lierman, PhD, Timothy Devos, MDPhD, Lucienne Michaux, MDPhD, Peter Vandenberghe, MDPhD
Journal: Blood
Blood (2015) 126 (23): 2837.
https://doi.org/10.1182/blood.V126.23.2837.2837
Published: 2015
Journal Articles

Analysis of Genotype, Phenotype and Outcome in a Belgian Cohort of Essential Thrombocythemia

Carla AL Assaf, Els Lierman, PhD, Florence Van Obbergh, MD, Timothy Devos, MD PhD, Johan Billiet, MD, Carlos Graux, MD PhD, Lucienne Michaux, MD PhD, Petros Papadopoulos, PhD, Peter Vandenberghe, MD PhD
Journal: Blood
Blood (2014) 124 (21): 5584.
https://doi.org/10.1182/blood.V124.21.5584.5584
Published: 2014
Journal Articles

In Vitro Characterization of Peripheral Blood Progenitor Cell Differentiation and Platelet Function in Essential Thrombocythemia (ET)

Petros Papadopoulos, PhD, Carla AL Assaf, Sanne Smits, Laura Gutierrez, PhD, Els Lierman, PhD, Peter Vandenberghe, MD PhD
Journal: Blood
Blood (2014) 124 (21): 1877.
https://doi.org/10.1182/blood.V124.21.1877.1877
Published: 2014
Journal Articles

JAK2 V617F-Negative and MPL W515K/L-Negative Essential Thrombocythemia: A High Resolution SNP Array Study

Carla AL Assaf, Els Lierman, PhD, Timothy Devos, MD, PhD, Carlos Graux, MD, PhD, Johan Billiet, MD, Peter Vandenberghe, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 5258.
https://doi.org/10.1182/blood.V122.21.5258.5258
Published: 2013
Journal Articles

Screening JAK2 V617F-Negative and MPL W515K/L-Negative Essential Thrombocythemia Patients For Mutations In SESN2, DNAJC17, ST13, TOP1MT , and NTRK1

Carla AL Assaf, Els Lierman, PhD, Timothy Devos, MD, PhD, Johan Billiet, MD, Carlos Graux, MD, PhD, Petros Papadopoulos, PhD, Peter Vandenberghe, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 5264.
https://doi.org/10.1182/blood.V122.21.5264.5264
Published: 2013
Journal Articles

Effects of Ponatinib and Other Novel TKI On Growth, Survival, and Function of Neoplastic Eosinophils Carrying FIP1L1/Pdgfra

Irina Sadovnik, M.Sc., Peter Valent, MD, Els Lierman, PhD, Harald Herrmann, M.D., Barbara Peter, D.V.M., Verena Suppan, BSc, Gabriele Stefanzl, MSc, Winfried F Pickl, MD, Jan Cools, PhD, Peter Vandenberghe, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 1760.
https://doi.org/10.1182/blood.V120.21.1760.1760
Published: 2012
Journal Articles

Translocation t(1;6)(p35.3;p25.2) Involves RCC1 and IRF4 and Is Not Restricted to Unmutated Chronic Lymphocytic Leukemia

Natalie Put, MD, Els Lierman, PhD, Iwona Wlodarska, PhD, Anne Hagemeijer, Peter Vandenberghe, MD, PhD, Lucienne Michaux, MD PhD
Journal: Blood
Blood (2012) 120 (21): 4584.
https://doi.org/10.1182/blood.V120.21.4584.4584
Published: 2012
Journal Articles

Ponatinib Is Active Against the CUX1-FGFR1 Fusion Kinase and Against Imatinib Resistance Mutations of the FIP1L1-PDGFRα Fusion Kinase and of KIT,

Els Lierman, PhD, Sanne Smits, Jan Cools, PhD, Barbara Dewaele, PhD, Maria Debiec-Rychter, MD PhD, Peter Vandenberghe, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 3848.
https://doi.org/10.1182/blood.V118.21.3848.3848
Published: 2011
Journal Articles

The Kinase Inhibitor TKI258 Is Active Against the Novel CUX1-FGFR1 Fusion Detected In a Patient with T-Lymphoblastic Leukemia/Lymphoma and t(7;8)(q22;p11)

Bartosz Wasag, PhD, Els Lierman, PhD, Peter Meeus, MD, Jan Cools, PhD, Peter Vandenberghe, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 2715.
https://doi.org/10.1182/blood.V116.21.2715.2715
Published: 2010